Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02113956 · ClinicalTrials.gov registry record · NA
Harnessing the Power of Text Messaging to Invigorate AMSM HIV Preventive Behavior
A NA study, sponsored by Center for Innovative Public Health Research.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
NCT02113956: Completed NA study, sponsored by Center for Innovative Public Health Research.
NCT02113956 is a NA study that has completed, run by Center for Innovative Public Health Research. The registered enrollment target is 302 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02113956, a NA study, has completed, sponsored by Center for Innovative Public Health Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether Guy2Guy (G2G), a text messaging-based healthy sexuality and human immunodeficiency virus (HIV) prevention program intervention for 14-18 year gay, bisexual and queer men, is associated with HIV preventive behavior (e.g., condom use) compared to an attention-matched control group.
Primary Outcome
The relative difference of unprotected anal and/or vaginal sex acts in the intervention versus control group at 3-months post-intervention. The count was truncated at 10 or higher to correct for over-dispersion.
Interventions
- BEHAVIORAL Guy2Guy (G2G)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT02113956 record still lists
NCT02113956 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Guy2Guy (G2G) is the first listed.
NCT02113956 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02113956 about?
NCT02113956 is a clinical study titled "Harnessing the Power of Text Messaging to Invigorate AMSM HIV Preventive Behavior". The purpose of this study is to examine whether Guy2Guy (G2G), a text messaging-based healthy sexuality and human immunodeficiency virus (HIV) prevention program intervention for 14-18 year gay, bisexual and queer men, is associated with HIV preventive behavior (e.g., condom use) compared to an atte...
What is the current status of trial NCT02113956?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2014-06. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02113956?
The interventions under investigation include: Guy2Guy (G2G) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02113956?
This trial is sponsored by Center for Innovative Public Health Research, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02113956's enrollment target sits among peer trials
302 330th of 2000 higher than 1,671 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia